Tag Archives: $INNO

$CYTR: $INNO and out with chaperones

Posted on May 17, 2011 by BioChef in Training

It has been an interesting couple of years for $CYTR. Their lead asset heading into 2008 was arimoclomol, a small molecule thought to activate Hsp70, which was placed on clinical hold (January 2008) over potential toxicology concerns in rats. While … Continue reading →

Posted in Jewel in the rough? | Tagged , , , , , | 1 Comment